New study aims to catch diabetic nerve damage earlier

NCT ID NCT07525882

Knowledge-focused Sponsor: Fenerbahce University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will measure nerve signals in 50 adults aged 45 to 76 with diabetic peripheral neuropathy. Researchers will compare these signals with blood sugar levels, diabetes duration, and neuropathy symptom scores. The goal is to find better ways to detect nerve damage early.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors identify nerve damage from diabetes earlier using simple nerve tests.
What could go wrong: This is a small, observational study that does not test any treatment. It only looks at relationships, so it cannot prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults aged 45 to 76 years with diabetic peripheral neuropathy who present to the Uzm. Dr. Gaye Yildirim Neurology and Clinical Neurophysiology Clinic and meet the eligibility criteria. Participants will have diabetes-related neuropathy diagnosed based on laboratory tests, clinical findings, and nerve conduction test results. Individuals with major neurological, systemic, infectious, oncological, renal, hepatic, or substance-related conditions that may affect peripheral nerve function will be excluded.

Ages

45 to 76 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants aged 45 to 76 years * Diagnosis of diabetes-related neuropathy based on laboratory tests, clinical findings, and nerve conduction test (NCT) results Exclusion Criteria: * History of autoimmune disease, cerebrovascular disease, or chronic infectious disease * Diagnosis of cancer or a history of chemotherapy and/or radiotherapy * Radicular neuropathy * Chronic kidney failure or liver failure * Alcoholism or other substance dependence * Mental or physical disability (including blindness) * Inability to speak Turkish

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus diabetic neuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes mellitus Diabetic peripheral neuropathy

How to take part

Only the study team decides who joins. These are the ways to reach them.

The places running it

1 site. The list below names each one and where it is.
The official record

The full official record for this study. This one lists no contact details, but it is the first place any would appear.

Open the record ↗
A doctor treating you

A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

New study aims to catch diabetic nerve damage earlier

What the study statuses mean